Chemokine receptor antagonist and cyclosporin in combined therapy
    1.
    发明授权
    Chemokine receptor antagonist and cyclosporin in combined therapy 失效
    趋化因子受体拮抗剂和环孢菌素联合治疗

    公开(公告)号:US06902728B1

    公开(公告)日:2005-06-07

    申请号:US09787335

    申请日:1999-09-16

    CPC分类号: C07K14/521 Y10S514/885

    摘要: The use of a chemokine receptor antagonist together with a cyclosporin to produce a pharmaceutical composition for treating or preventing rejection of transplanted organs, tissues or cells is herein disclosed. Said pharmaceutical compositions for the simultaneous, sepatate or sequential use of its active ingredients for the above specified therapy are also disclosed and claimed. In particular, the use of Met-RANTES together with cyclosporin A to produce a pharmaceutical composition for the treatment of renal allograft transplant rejection is experimentally shown.

    摘要翻译: 本文公开了将趋化因子受体拮抗剂与环孢菌素一起用于产生用于治疗或预防移植器官,组织或细胞排斥的药物组合物。 用于同时,分离或顺序使用其用于上述指定治疗的活性成分的所述药物组合物也被公开和要求保护。 特别地,实验上显示使用Met-RANTES与环孢菌素A一起制备用于治疗肾同种异体移植排斥的药物组合物。